Pro-Dex Inc New (PDEX) is a publicly traded Healthcare sector company. As of May 21, 2026, PDEX trades at $63.59 with a market cap of $188.88M and a P/E ratio of 18.23. PDEX moved +2.55% today. Year to date, PDEX is +63.92%; over the trailing twelve months it is +42.41%. Its 52-week range spans $23.47 to $70.26. Rallies surfaces PDEX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded PDEX stock?
Rallies tracks politician and congressional stock disclosures for PDEX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
CABILLOT RAYMOND E sold 7.26K (~$363.22K) on Apr 1, 2025.
CABILLOT RAYMOND E sold 836 (~$41.80K) on Mar 31, 2025.
CABILLOT RAYMOND E sold 842 (~$42.10K) on Mar 28, 2025.
PDEX Analyst Consensus
PDEX analyst coverage data. Average price target: $0.00.
Common questions about PDEX
Which politicians traded PDEX stock?
Rallies tracks politician and congressional stock disclosures for PDEX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in PDEX?
Yes. Rallies tracks politician and congressional stock disclosures for PDEX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is PDEX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PDEX. It does not provide personalized investment advice.
